期刊文献+

PARPl特异性siRNA对前列腺癌PC3细胞增殖的影响及其机制研究

Effects and underlying mechanism of siRNA targeting PARP1 on the proliferation of PC3 cells
原文传递
导出
摘要 目的研究多聚腺苷二磷酸核糖聚合酶1(PARPl)特异性小分子干扰RNA(siRNA)对雄激素非依赖性前列腺癌PC3细胞株增殖的影响并初步探讨其作用机制。方法设计合成3条PARPl特异性siRNA序列,进行脂质体转染后,通过RT—PCR、蛋白质印迹法检测其对PARPl的干扰效果,筛选出最佳干扰效果的2条siRNA序列;通过单溶液细胞增殖检测法检测干扰PC3细胞内源性PARPl表达对细胞增殖的影响,并检测细胞内Akt及其下游GSK3B活化水平的变化。结果与空白对照组相比,转染阴性对照序列对PARPl的mRNA和蛋白表达水平无明显影响,而转染RNA干扰序列1706、2003和2907均可以明显干扰PARPl的表达,其中mRNA抑制率分别为(52.07±4.65)%、(44.38±9.15)%和(22.05±6.65)%,蛋白抑制率分别为(86.86±4.94)%、(83.30±7.18)%和(63.05±10.19)%。RNA干扰序列1706和2003对PC3细胞的增殖抑制率分别为(38.93±3.87)%和(34.93±1.21)%,并可以下调细胞内Akt、GSK3B的磷酸化水平。结论PARPl特异性siRNA可以明显干扰PC3细胞内源性PARPl的表达并抑制细胞增殖,该抑制作用与Akt的活化抑制以及其下游GSK3B的激活有关。 Objective To observe the effects and study the underlying mechanism of siRNA targe- ting PARP1 on the proliferation of androgen independent prostate cancer PC3 cell line. Methods Three specific siRNA sequences targeting PARP1 were designed and synthesized. And two sequences which had better interfering effect on the expression of PARP1 were evaluated and selected through lipofectamine trans- fection, RT-PCR and Western Blot. The effect of PARP1 silencing on the proliferation of PC3 cells was ob- served with MTS assay and the levels of the phosphorylation of Akt and GSK3[3 were detected by Western Blot. Results Compared to the blank control group, the transfected group with the negative control se- quence had no significant impact on the expression of PARP1, however the transfected group with siRNA- 1706, -2003 or -2907 could significantly suppress the mRNA and protein expression of PARPI. The mRNA inhibition rate reached to (52.07 ±4.65)%, (44.38 ±9.15)% and (22.05±6.65)%, respectively; and the protein inhibition rate reached to ( 86.86 ± 4.94) %, ( 83.30 ± 7.18 ) % and (63.05 ± 10, 19 ) %, respectively. The siRNA-1706 and -2003 could significantly inhibit the proliferation of PC3 ceils; the inhibi- tion rate was (38.93 ± 3.87)% and (34.93 ± 1.21 )%. And they also could down-regulate the intracellu- lar levels of phosphorylated Akt and GSK313 in PC3 cells. Conclusion PARPl-targeted siRNA can sig- nificantly suppress the expression of endogenous PARP1 and inhibit the proliferation of PC3 cells, which is related to the inhibition of Akt activity and the activation of GSK3β.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2013年第2期130-134,共5页 Chinese Journal of Urology
基金 国家自然科学基金青年基金(30901495) 广州市科技和信息化局计划项目(2011J4100049)
关键词 聚ADP核糖聚合酶类 RNA干扰 前列腺肿瘤 细胞增殖 Poly (ADP-ribose) polymerases RNA interference Prostatic neoplasms Cellproliferation
  • 相关文献

参考文献18

  • 1Gibson BA, Kraus WL. New insights into the molecular and cel- lular functions of poly (ADP-ribose) and PARPs. Nat Rev Mol Cell Biol, 2012, 13: 411--424.
  • 2吴文起,曾少华,李舒珏,梁叶萍,欧莉莉,曾国华.多聚腺苷二磷酸核糖聚合酶在前列腺癌LNCaP细胞株中的表达及意义[J].中华泌尿外科杂志,2011,32(12):839-842. 被引量:3
  • 3曾少华,曾国华,李舒珏,梁叶萍,欧莉莉,吴文起.PARP抑制剂5-AIQ对雄激素非依赖性前列腺癌细胞PC3的作用[J].广东医学,2012,33(12):1720-1722. 被引量:3
  • 4Sodhi RK, Singh N, Jaggi AS. Poly (ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications. Vascul Pharmacol, 2010, 53: 77-87.
  • 5Veres B, Radnai B, Gallyas F Jr, et al. Regulation of kinase cascades and transcription factors by a poly (ADP-ribose) poly- merase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide- induced inflammation in mice. J Pharmacol Exp Ther, 2004, 310 : 247-255.
  • 6Kummar S, Chen A, Parchment RE, et al. Advances in using PARP inhibitors to treat cancer. BMC Med, 2012, 10: 25.
  • 7Abd Elmageed ZY, Naura AS, Errami Y, et al. The poly ( ADP- ribose) polymerases (PARPs) : new roles in intracellular trans- port. Cell Signal, 2012, 24: 1-8.
  • 8Plummer R. Poly (ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer?. Breast Cancer Res, 2011, 13: 218-223.
  • 9Calabrese CR, Batey MA, Thomas HD, et al. Identification of potent nontoxic poly (ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies. Clin Cancer Res, 2003, 9: 2711-2718.
  • 10Barreto-Andrade JC, Efimova EV, Mauceri H J, et al. Response of human prostate cancer cells and tumors to combining PARP in- hibition with ionizing radiation. Mol Cancer Ther, 2011, 10: 1185-1193.

二级参考文献41

  • 1黄胜辉,黄志勇.PARP-1:一个肿瘤治疗的新靶点[J].世界华人消化杂志,2006,14(9):841-847. 被引量:11
  • 2郝兰香,王娅兰,李圆圆.大肠癌PARP表达与P-selectin和ICAM-1表达的相关性[J].基础医学与临床,2006,26(8):882-887. 被引量:17
  • 3Albert JM, Cao C, Kim KW, et al. Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res, 2007,13 : 3033-3042.
  • 4Bryant HE, Schuhz N, Thomas HD, et al. Specific killing of BRCA2-defieient tumors with inhibitors of poly (ADP-ribose) polymerase. Nature, 2005, 434:913-917.
  • 5Fong PC, Boss DS, Yao TA, et al. Inhibition of poly ( ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med, 2009, 361 : 123-134.
  • 6Lilyestrom W, van der Woerd MJ, Clark N, et al. Structural and biophysical studies of human PARP-1 in complex with damaged DNA. Mol Biol, 2010, 395: 983-994.
  • 7Tentori L, portarena I, Graziani G. Potential clinical application of poly (ADP-ribose) polymerase inhibition. Pharmacol Res, 2002, 5: 73-85.
  • 8Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet, 2001, 27 : 247-254.
  • 9Rouleau M, Patel A, Hendzel M J, et al. PARP inhibition PARP1 and beyond. Nat Rev Cancer, 2010, 10: 293-301.
  • 10Trofimova I, Dimtchev A, Jung M, et al. Gene therapy for prostare cancer by targeting poly (ADP-ribose) polymerase. Cancer Res, 2002, 62: 6879-6883,.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部